Oxford Biomedica (UK) Limited

Funded awards at Oxford Biomedica (UK) Limited.

Funded awards
6
Total Funding
£10.6M
Average published award
£1.8M
Active funded awards
0

Data as of 16 July 2026

See funded awards Open the Map

The biggest topic here is Cancer — 3 grants (50%). The busiest year was 2017, with 2 grants.

Top topics

View data table
FunderFunded awards
Cancer3
Digestion, Kidneys & Other Organs2
Brain & Nervous System1

Funded Awards by Year

View data table
YearFunded awards
20101
20131
20141
20172
20181

Grants

Oxford BioMedical 2017/2018 lentiviral vector capacity expansion projectOxford Biomedica (UK) LimitedUKRI£3.0M2017Completed
Clinical Development of OXB-102Oxford Biomedica (UK) LimitedInnovateUK£2.2M2014Completed
Digitilisation of medicines manufacturingOxford Biomedica (UK) LimitedUKRI£2.0M2018Completed
Development of a novel therapeutic treatment to engineer corneas to resist graft rejectionOxford Biomedica (UK) LimitedInnovateUK£1.8M2013Completed
Industrial Viral Vector Manufacturing Using Advanced Process Analytical TechnologiesOxford Biomedica (UK) LimitedInnovateUK£1.3M2017Completed
In vivo evaluation of the therapeutic potential of VEGF-B(-receptor) lentiviral gene transfer for treatment of ALSOxford Biomedica (UK) LimitedMNDA£255K2010Completed